Inventor

YOSHIYUKI TENDA

Inventor

Overview

3→

Patents

2024–2025

Patent span

Chemistry

Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes21%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%

C07KPeptides21%

C12NMicroorganisms or enzymes21%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture14%

PatentTitleYear

12,304,951Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody2025 12,227,586Anti-CLDN4/anti-CD137 bispecific antibody2025 11,897,954Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to ASTELLAS PHARMA INC (3)· patent assignee history

2024–2025Patents assigned to NAT CANCER CT (3)· patent assignee history

2024–2025Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ASTELLAS PHARMA INC	3	2024–2025
NAT CANCER CT	3	2024–2025

Locations

Location	Patents	Span
JP	3	2024–2025